300149 睿智醫藥
按盤價 
7.120 -0.160 (-2.198%)
7.120 -0.160 (-2.198%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -4.401 | -48.477 | 16.827 | -18.316 | 6.549 |
| 總資產報酬率 ROA (%) | -2.686 | -29.372 | 9.037 | -9.647 | 3.918 |
| 投入資產回報率 ROIC (%) | -3.024 | -32.939 | 10.070 | -10.735 | 4.396 | 邊際利潤分析 |
| 銷售毛利率 (%) | 19.225 | 25.935 | 25.423 | 31.690 | 38.315 |
| 營業利潤率 (%) | -9.263 | -82.255 | 56.350 | -21.021 | 13.460 |
| 息稅前利潤/營業總收入 (%) | -8.202 | -81.322 | 55.826 | -16.483 | 16.977 |
| 淨利潤/營業總收入 (%) | -8.598 | -80.549 | 27.320 | -23.783 | 10.396 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 83.072 | 6.392 | -11.315 | 2.377 | 78.224 |
| 價值變動淨收益/利潤總額(%) | -10.895 | 0.098 | 190.871 | -3.061 | 48.711 |
| 營業外收支淨額/利潤總額(%) | 0.717 | 0.362 | -2.575 | 1.559 | -3.061 | 償債能力分析 |
| 流動比率 (X) | 1.797 | 1.704 | 1.749 | 0.694 | 1.168 |
| 速動比率 (X) | 1.767 | 1.639 | 1.691 | 0.625 | 1.098 |
| 資產負債率 (%) | 35.563 | 39.988 | 37.762 | 52.839 | 40.499 |
| 帶息債務/全部投入資本 (%) | 8.882 | 10.329 | 15.544 | 31.887 | 31.884 |
| 股東權益/帶息債務 (%) | 802.877 | 643.036 | 443.387 | 162.182 | 206.044 |
| 股東權益/負債合計 (%) | 178.042 | 147.585 | 163.121 | 88.150 | 145.454 |
| 利息保障倍數 (X) | -7.271 | -66.008 | 62.684 | -3.384 | 4.335 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 87.716 | 95.718 | 91.814 | 76.617 | 96.373 |
| 存貨周轉天數 (天) | 8.877 | 15.094 | 20.310 | 19.267 | 24.163 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 08/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
